Format

Send to

Choose Destination
Cell Cycle. 2018;17(3):362-366. doi: 10.1080/15384101.2018.1426412. Epub 2018 Mar 19.

DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.

Author information

1
a August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University , Ratsupites 5, LV-1067 Riga , Latvia.
2
b Latvian Biomedical Research & Study Centre , Ratsupites 1, Riga LV-1067 , Latvia.
3
c Faculty Institute for Cancer Sciences, University of Manchester , Manchester , M13 9WL , UK.

Abstract

The epigenetic mechanisms underlying chemoresistance in cancer cells resulting from drug-induced reversible senescence are poorly understood. Chemoresistant ESC-like embryonal carcinoma PA1 cells treated with etoposide (ETO) were previously found to undergo prolonged G2 arrest with transient p53-dependent upregulation of opposing fate regulators, p21CIP1 (senescence) and OCT4A (self-renewal). Here we report on the analysis of the DNA methylation state of the distal enhancer (DE) and proximal enhancer (PE) of the Oct4A gene during this dual response. When compared to non-treated controls the methylation level increased from 1.3% to 12.5% and from 3% to 19.4%, in the DE and PE respectively. It included CpG and non-CpG methylation, which was not chaotic but presented two patterns in each enhancer. Discorrelating with methylation of enhancers, the transcription of Oct4A increased, however, a strong expression of the splicing form Oct4B was also induced, along with down-regulation of the Oct4A partners of in the pluripotency/self-renewal network Sox2 and Lin28. WB demonstrated disjoining of the OCT4A protein from the chromatin-bound fraction. In survival clones, methylation of the DE was considerably erased, while some remnant of methylation of the PE was still observed. The alternative splicing for Oct4B was reduced, Oct4A level insignificantly decreased, while the expression of Sox2 and Lin28 recovered, all three became proportionally above the control. These findings indicate the involvement of the transient patterned methylation of the Oct4A enhancers and alternative splicing in the adaptive regulation of cell fate choice during the p53-dependant dual state of reversible senescence in ESC-like cancer stem cells.

KEYWORDS:

DNA damage; Oct4A; alternative splicing; cell senescence; embryonal carcinoma; enhancer methylation; transient pluripotency suppression; wt TP53

PMID:
29372665
PMCID:
PMC5914730
DOI:
10.1080/15384101.2018.1426412
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center